03/13/2025
10:10 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
3:11 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
12:58 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
12:02 PM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
11:42 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
3:08 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:08 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
12:39 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:17 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:43 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:46 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/28/2025
3:48 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:31 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:36 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
10:20 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
9:18 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
9:14 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
3:06 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:07 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:09 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:11 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
10:38 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
9:59 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
10:13 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
3:07 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
2:45 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:30 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:31 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:33 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:21 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
10:29 AM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
10:34 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
3:17 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:14 PM | Vertex Pharmaceuticals (Filer)
| Form S-3ASR | |
02/13/2025
3:53 PM | Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
3:46 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:48 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:50 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:52 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:26 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
3:21 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Warning: “DOGE Collapse” imminent (Ad) Elon Strikes Back
You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead. Click here to see what they’re predicting now. |
02/12/2025
3:24 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:34 AM | FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
10:57 AM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/11/2025
10:05 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/11/2025
8:49 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2025
3:43 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:45 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:37 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:38 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:32 PM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:35 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:07 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
2:51 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
9:31 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
3:15 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
1:58 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
3:11 PM | Vertex Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/17/2024
3:12 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:12 PM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
9:04 AM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:47 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:23 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:08 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
10:47 AM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
8:52 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:17 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
2:34 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
2:25 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:06 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:05 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
11:27 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
12:16 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
9:27 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
9:23 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
3:09 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:11 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
8:54 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
8:56 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:11 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:09 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
12:56 PM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:38 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
9:50 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
10:48 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:08 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
9:05 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
9:51 AM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
12:13 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:21 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
12:45 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
 When you see what could happen – I think you’ll be excited. |
05/20/2024
2:32 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
7:36 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
7:25 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/15/2024
11:20 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
10:41 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
10:50 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2024
7:01 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/08/2024
7:54 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/03/2024
3:05 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
